Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lean Meds vs Primary Clinic (Direct GLP)

Lean Meds
Graded #31

Higher grade

vs+16.3
Primary Clinic (Direct GLP)
Graded #231

Lower grade

The verdict

Lean Meds takes it — 81.8/100 to 65.5/100.

Lean Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lean Meds holds one price at every dose, names four dispensing pharmacies and its compounding class, and undercuts the field on both molecules.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLean Meds +32
97
65
Dose & formulationLean Meds +18
72
54
Clinical oversightLean Meds +3
78
75
Labs & monitoringPrimary Clinic (Direct GLP) +6
70
76
FulfillmentLean Meds +24
97
73
Contract termsLean Meds +26
67
41
Lean Meds · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricLean MedsPrimary Clinic (Direct GLP)
WeighScore81.8/10065.5/100
GradeB−C
Scorecard rank#31#231
Semaglutide$79/mo (one-month plan, flat at every dose)$85/mo (0.25-0.75 mg band, membership required, compounded)
Tirzepatide$109/mo (one-month plan, flat at every dose)$133/mo (1.25-2.5 mg band, membership required, compounded)
CoverageAll 50 states10 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Lean Meds

Graded #31 · B−

Strengths

  • The price holds at every dose — stated as “same price, every dose” — so titration does not raise the bill
  • $79 for semaglutide and $109 for tirzepatide on a one-month plan are at the low end of what this ranking records
  • States its compounding class in the footer of every page: state-licensed 503A compounding pharmacies
  • Names four dispensing pharmacies with addresses and phone numbers, and names the prescribing medical group
  • A nutritionist and unlimited check-ins are included, and shipping is free

Where it loses points

  • The $49 in the homepage hero is the twelve-month tier, not the month-to-month rate, and the same page carries a “price increases in” countdown with no dated deadline
  • A homepage chip reads “no auto rebill” while the Terms describe automatic charging at recurring intervals until canceled
  • An “eligible for insurance” chip sits against an FAQ calling the service self-pay and Terms barring reimbursement from any payor
  • The refund page signs both “Leanmeds, Inc.” and “Leanmeds LLC”, chooses Florida law and then fixes venue in Fulton County, Georgia
  • A satisfaction rating and a member count are published with no platform and no denominator
  • No individual clinician or NPI is published — the medical group is named, its clinicians are not

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labeled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard